Novartis commits $500 million to Russia
This article was originally published in Scrip
Executive Summary
Novartis says it will invest $500 million in Russia over five years in a bid to "expand [its] commercial presence in a key emerging market". The investment includes a new plant in St Petersburg, R&D partnerships and public health initiatives.